Now in its 18th year, DDW is the world’s only truly global business review of all aspects of drug discovery and development, having firmly established itself as a highly-respected and ‘must read’ journal within the drug discovery and development arena. DDW is renowned for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised ‘platform’ for ‘industry Gurus’ to discuss and encourage debate on some of the more challenging issues surrounding the technological, strategic and business facets of pharma and biopharmaceutical industry. Indeed, there is no doubt that articles DDW has carried over recent years have had an impact in forming and moulding the drug discovery and development industry that we see today and will continue to see over the next few years. DDW has always adhered to the maxim... ‘Turning Science Into Business’.
DDW examines the advances in new science and technology with a view to the commercial implications of implementing those advances and whether they can truly bring benefits to the drug discovery and development process with the goal of reducing costs and attrition rates while, ultimately, bringing new truly efficacious and safe therapeutics to the market faster.
DDW is totally distinguishable from other journals in that it reaches out to a truly global audience at both bench and boardroom level, allowing them to understand the new technologies, science and strategies and the impact they can have on their particular segments of the business. Scientist and CEO alike can profit from the uncomplicated style of the editorial and, furthermore, gain a wealth of information on a diverse range of life science topics. In our articles, we continually challenge the industry to look at new ways of overcoming discovery bottlenecks, embrace new technologies, form relationships with discovery partners and build next-generation technology platforms.
2018 EDITORIAL FOCUS
WINTER 2017/18 Tech Focus: Automation Partnering, Precision Medicine, Oncology, Transforming R&D Productivity, Kinases, Liquid Handling, Binding Kinetics, High Throughput Screening
SPRING 2018 Tech Focus: Oncology and Immunology Immunotherapy, T-cell-based tools, Flow Cytometry, Genome Editing, RNAi, Antibodies, Immuno-Oncology, Biomarkers
SUMMER 2018 Tech Focus:Target Identification and Validation Next Gen Sequencing, Cell-Based Assays, Compound Management, Drug Repositioning, Mass Spectrometry, Cell Therapy, Genomics, Fragment-Based Drug Design
FALL 2018 Tech Focus: Assay Development and Screening Phenotypic Screening, High Content Imaging, High Throughput Screening, ADME-Tox, Animal Model Development, Stem Cells, Epigenetics, Live Cell Imaging
Editorial is always sourced on the basis of DDW’s well known maxim of turning science into business. We commission articles from Pharma, Academia and the Technology Community that can talk candidly about the commercial potency of implementing new technologies and the impact these ultimately will have in discovering new drugs. We strive to keep the editorial balanced and objective and appeal to both camps, the scientist and, of course, the business leaders within the Pharma, Biotech and Academic Institutions.
UPCOMING EVENTS IN 2018
Sponsored by DDW, where we will have a presence and the potential for bonus circulation
SLAS 2018 - 3-7 February 2018, San Diego, USA
Flow Chemistry Europe 2018 - 6-7 February 2018, Cambridge, UK
ELRIG Robotics and Automation 2018 - 28 February 2018, Stuttgart, Germany
BioEngineering 2018 - 26-27 March 2018, Boston, USA
Circulating Biomarkers World Congress 2018 - 28-29 March 2018, Boston, USA
AACR 2018 - Annual Meeting 14-18 April 2018, Chicago, USA
ELRIG Research and Innovation 2018 - 17-18 April 2018, Cambridge, UK
ELRIG Discovery Technologies 2018 - 23 May 2018, Alderley Park, UK
Stem Cells and Antibodies in Drug Discovery Europe 2018 - 24-25 May 2018, Cambridge, UK
High-Content and Phenotypic Screening Europe 2018 - 24-25 May 2018, Cambridge, UK
Lab-on-a-Chip and Microfluidics Europe 2018 - 5-6 June 2018, Rotterdam, The Netherlands
Point-of-Care Diagnostics Europe 2018 - 5-6 June 2018, Rotterdam, The Netherlands
Organ-on-a-Chip, Tissue-on-a-Chip Europe 2018 - 5-6 June 2018, Rotterdam, The Netherlands
ISSCR 2018 - Annual Meeting 20-24 June 2018, Melbourne, Australia
ELRIG Drug Discovery 2018 - 9-10 October 2018, London, UK
AAPS 2018 - 4-8 November 2018, Washington, DC, USA
Society for Neuroscience (SFN) Annual Meeting 2018 - 3-7 November 2018, San Diego, USA
ELRIG Pharmaceutical Flow Cytometry and Imaging 2018 - 14-15 November 2018, Stevenage, UK
ASCB Annual Meeting 2018 - 8-12 December 2018, San Diego, USA
WHAT OUR READERS AND ADVERTISERS THINK....
“DDW is an excellent resource for in-depth articles on topics which touch the drug discovery industry. Its rich editorial content has made it a must-read publication and therefore relevant to our business. The magazine’s readers constitute our customers and potential customers, so from an advertiser’s perspective, we can be assured that our message will reach our target audience with every issue.”
“Getting the right message through the right channel can sometimes be challenging for a marketer. DDW has been our partner for many years because it allows us to reach the desired target audience and create impactful marketing campaigns. This renowned publication guarantees awareness within the life science industry, whether it is through print, online adverts or dedicated email blasts.”
“As a global head of R&D for a large pharmaceutical company my time is limited. DDW allows me to keep up with the latest technologies and science while understanding how I can implement those advancements to drive my business further.”
“DDW delivers a unique mix of scientific news and business analysis that pharma and biopharmaceutical decision makers crave. As such, it is among one of our favourite publications when we want to publicise new life science products and services, especially in Europe. And last, but certainly not least, we appreciate that DDW is always seeking new ways to improve the magazine to stay current with the ever-changing media landscape.”
“As a small company we have the challenge of limited resources and needing a global reach for our marketing efforts. DDW delivers a quality, directed outlet. We have had excellent success reaching high quality new customers worldwide with DDW. Quality counts and DDW delivers for our customers and for our company.”